Chief Scientific Officer of Keros Therapeutics, Inc. (NASDAQ:KROS), Lachey Jennifer, sells 5,300 shares worth $318,026

According to Keros Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:43 PM, company Chief Scientific Officer, Lachey Jennifer disclosed selling 5,300 shares at a cost of $60.00. At the time of this transaction (Apr 12), this trade was worth $318,026 in total. As of Apr 12, Lachey Jennifer now owns 71,187 shares in total worth about $4,375,864.89.

For the last few recent trades made by Keros Therapeutics, Inc. (NASDAQ:KROS) Chief Scientific Officer, Lachey Jennifer, we have the following information:

Posted by George Daniels on Wednesday April 14 2021, 7:19 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0